The title compound, cyclo(Phe ) was obtained as the minor diastereoisomer in a ring-closing reductive amination reaction and adopts an R configuration.
The title compound, cyclo(Phe ) was obtained as the minor diastereoisomer in a ring-closing reductive amination reaction and adopts an R configuration.
Chemical context
Cyclic peptidomimetics, with their ability to mimic the secondary structure of peptides, represent a very attractive class of macrocycles. While still being modular and promising a strong affinity for a broad range of biological targets, they have improved pharmacological properties and bioavailability compared to linear peptides.
During our research, we have developed a highly selective cyclization method to access a new class of cyclic carbo-isos- ISSN 2056-9890 teric depsipeptides (Gué ret et al., 2014) . Our strategy allowed the formation of a novel APO motif which is believed to mimic the glycine amino-acid structure. In order to study the secondary structure of our peptidomimetic motifs, we have started crystallization trials for various analogues. The first compound for which we obtained crystals suitable for single crystal structure determination was the title compound cyclo(Phe 
Structural commentary
The cyclic carbo-isosteric depsipeptide cyclo(Phe -CO 2 CH 2 COCH 3 . The two natural amino acids, Phe 1 and Phe 4 are in an l-configuration, whereas the unnatural alanine unit, Ala 2 is in a d-configuration, following the Cahn-IngoldPrelog priority rules or CORN rules (Cahn et al., 1966) . Based on the known stereochemistry of the backbone amino acids, the absolute configuration of the newly formed methyl stereocentre to the secondary amine (N9) of the minor diastereoisomer could be unambiguously assigned as C19R. The result is supported by a Flack x parameter of 0.10 (11), calculated using the quotient method (Parsons & Flack, 2004) as implemented in the 2013 version of SHELXL (Sheldrick, 2008) . The structure of the title compound in the crystal, including the residue-labelling scheme, is shown in Fig. 1 .
The secondary structure of the cyclic peptidomimetic, in which all peptidic bonds adopt a trans conformation, is stabilized by a -turn containing an intramolecular hydrogen bond (Table 1 , Fig. 2 ) between the carbonyl oxygen O23 of the first residue (Phe 1 ) and the amide hydrogen N15-H15 of the residue located three residues after the first residue (Phe 4 ). The related torsion angle values fall into the corresponding type II 0 -turn Ramachandran plot area (Ramachandran et al., 1963) . The APO peptidomimetic motif adopts an open -turn with a loose hydrogen bond between the carbonyl oxygen of the lactone unit (O25) of the first residue (Phe 4 ) and the secondary amine (N9) of the residue located two residues after the first (Phe 1 ). Selected backbone torsion angles are given in Table 2 and a review on the secondary structure of peptides and proteins is given by Smith et al. (1980) . The structure of the title compound in the crystal, including the residuelabelling scheme. Non-H atoms are represented by displacement ellipsoids drawn at the 50% probability level. H atoms are represented as small spheres of arbitrary radius. The atom labelling has been omitted for clarity but is displayed in Fig. 2 .
Figure 2
The atom-and residue-labelling scheme of the title compound, showing the intramolecular hydrogen bond. All atoms are represented as small spheres of arbitrary radius. Table 1 Hydrogen-bond geometry (Å , ). 
Supramolecular features
The cyclo(Phe ) molecules align in the crystal in infinite chains parallel to the b axis (Fig. 3) . Within each chain, the peptide molecules are linked via hydrogen bonds between O25 and N21-H21 (blue). The individual chains are loosely connected via hydrogen bonds between O34 and N18-H18 (orange).
Synthesis and crystallization
Step 1 The linear precursor H 2 N-Phe 1 -d-Ala 2 -Gly 3 -Phe 4 -CO 2 CH 2 COCH 3 (90.7 mg, 152 mmol) was stirred in hydrogen chloride (4 M in 1,4-dioxane, 20.0 ml) at 0 C for 1 h, then at room temperature for 2 h. The reaction mixture was concentrated under reduced pressure and the resulting amine was used in the following step without further purification.
Step 2 The previously obtained crude amine was dissolved in DMF (15.2 ml) and acetic acid (152 ml, 2.66 mmol) was added. The reaction mixture was stirred at room temperature for 1.5 h.
Step 3 To the imine reaction mixture, sodium cyanoborohydride (11.5 mg, 182 mmol) was added followed by methanol (3.80 ml), leading to a final concentration of 8 mM with a 1:4 ratio of MeOH/DMF. The resulting reaction mixture was stirred at room temperature for 16 h and then concentrated under vacuum. The crude residue was directly purified by preparative RP-HPLC on an Atlantis Prep T3 OBD (30 Â 150 mm; 5 mm) column at a flow rate of 60 ml/min with a step gradient of 5 to 15% for 2.5 min, 15 to 35% for 12 min, 35 to 45% for 2 min, then 45 to 95% for 0.1 min of MeCN in H 2 O + 0.1% TFA. Selected fractions were combined and lyophilized to yield the desired cyclic peptidomimetic (65.0 mg, 85%) as a white fluffy solid, TFA salt and a 81:19 mixture of two diastereoisomers. A fraction of the purified mixture of diastereoisomers (29 mg) was re-purified by preparative chiral-HPLC using a Chiralpak (20 Â 250 mm; 5 mm) column at a flow rate of 12 ml/min with an optimized n-heptane/ i-PrOH/MeOH/DEA (80:18:2:0.03) isocratic gradient to afford the major diastereoisomer (16.0 mg, d.e. = 98.9%) as a desalted white fluffy solid and the minor diastereoisomer (3.2 mg, d.e. = 99.4%) as desalted white fluffy solid.
Crystallization of minor diastereoisomer Crystals of the title compound were obtained by dissolving the minor diastereoisomer in a minimum amount of ethyl acetate and n-heptane (1:1) from which the solvents were allowed to slowly evaporate at room temperature. Table 2 Selected backbone torsion angles ( ). Computer programs: SMART (Bruker, 2003) , SAINT (Bruker, 2004) , SHELXS97 and SHELXL97 (Sheldrick, 2008) , PLATON (Spek, 2009 ) and publCIF (Westrip, 2010) . 
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 3 . The C-bound H atoms were calculated in idealized positions (C-H = 0.98-1.00 Å ) and refined using a riding model with U iso (H) = 1.2U eq (parent atom). The hydrogen atoms of the amide groups and the hydroxy group were located in a difference Fourier map and allowed to refine freely. 
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